Clinical validation of a saliva-based matrix metalloproteinase-1 rapid strip test for detection of oral cavity cancer

Biomed J. 2024 Feb;47(1):100594. doi: 10.1016/j.bj.2023.04.002. Epub 2023 Apr 10.

Abstract

Background: We previously identified matrix metalloproteinase-1 (MMP-1) as one of the most promising salivary biomarkers for oral squamous cell carcinoma (OSCC) and developed a sensitive ELISA for MMP-1 with good performance in detection of OSCC using a cohort of 1160 saliva samples.

Methods: A time-saving rapid strip test (RST) for MMP-1 was developed in this study and its diagnostic performance compared with ELISA using saliva samples from a new cohort of 603 subjects (171 healthy controls, 236 patients with oral potentially malignant disorders, and 196 OSCC patients).

Results: Salivary MMP-1 levels measured using RST and ELISA were highly comparable and both assays could effectively distinguish between OSCC and non-cancerous groups. Similar to ELISA, receiver operating characteristic curve analysis of the MMP-1 RST was effective in identifying patients with OSCC at different oral cavity sites and stages.

Conclusions: Salivary MMP-1 can be sensitively detected using both RST and ELISA methods. Our newly developed point-of-care MMP-1 RST is a promising in vitro diagnostic device (IVD) that may serve as a novel auxiliary tool in the routine clinical detection and monitoring of OSCC.

Keywords: ELISA; MMP-1; Oral cancer diagnosis; Point of care; Rapid strip test; Salivary biomarker.

MeSH terms

  • Biomarkers, Tumor / analysis
  • Carcinoma, Squamous Cell* / diagnosis
  • Head and Neck Neoplasms*
  • Humans
  • Matrix Metalloproteinase 1
  • Mouth Neoplasms* / diagnosis
  • Saliva / chemistry
  • Squamous Cell Carcinoma of Head and Neck

Substances

  • Matrix Metalloproteinase 1
  • Biomarkers, Tumor